Forbes -- SAN JUAN, Puerto Rico -- The U.S. Food and Drug Administration has warned drug giant Bristol-Myers Squibb Co. of possible sanctions if it fails to correct “significant violations” of good manufacturing practices at one of its two plants in Puerto Rico.
